Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc. develops and commercializes oral appliance-based therapies and related clinical protocols for obstructive sleep apnea and other sleep-disordered breathing conditions. The company works through trained dental and medical providers and also operates sleep and airway medicine centers that support diagnosis, treatment, and patient management in the United States.

−106,5 %

60,4 %

−121,4 %

+16,0 %

0.24

0.24

— Vivos Therapeutics, Inc.
%
Oral appliance systems45% Custom oral devices used in sleep apnea and airway treatment protocols.
Clinical services and enrollments20% VIP enrollments, training, and support services for provider networks.
Sleep center operations25% Diagnostic, consulting, and treatment services delivered through managed centers.
Adjunctive therapies and support10% Additional therapies, technical support, and patient-care services tied to the platform.

The company sells to dental practices, sleep medicine providers, and medical professionals who use its appliances and...

  • VIP dental practicesprimary

    Independent dentists that enroll to prescribe and support Vivos oral appliance therapy and related services.

  • Sleep and airway medicine centersprimary

    Managed centers that provide diagnostics, consulting, and treatment pathways for sleep-disordered breathing.

  • Medical sleep providerssecondary

    Physicians and advanced practice clinicians who participate in center-based sleep care and referrals.

  • Patients with OSA and snoringprimary

    End users receiving appliance-based therapy, diagnostics, and adjunctive treatment services.

Vivos is primarily a United States business, with product commercialization, provider training, and sleep-center...

  • •United States is the core operating and revenue market
  • •Provider training and center operations are concentrated in the U.S.
  • •International patient treatment experience has been referenced worldwide
  • •Middle East-North Africa distribution collaboration is still pre-revenue
  • •Imported components create exposure to trade policy and tariffs

The company is shifting from a provider-enrollment model toward owning or partnering with sleep and airway medicine...

01
Build a center-based sleep medicine modelshort-term

Owning or managing centers can create more direct patient access and additional revenue streams.

02
Expand strategic alliances and acquisitionsmedium-term

Partnerships can increase patient volume and broaden distribution without relying only on VIP recruitment.

03
Strengthen clinical validationmedium-term

Clinical evidence supports provider adoption, payer acceptance, and regulatory credibility.

Vivos faces execution risk as it transitions to a new operating model that depends on acquisitions, alliances, and...

critical

Liquidity and financing risk

The company has indicated it needs additional capital to fund operations and strategic objectives.

Scope
Debt/equity financing, going concern
Materiality
high
high

Transition to a new sales and distribution model may fail

The company is moving away from VIP recruitment toward center-based care, which has limited operating history.

Scope
Revenue growth, customer acquisition, operating model
Materiality
high
high

Acquisition and integration risk

Integrating sleep centers can be costly and operationally disruptive, affecting patients, staff, and standards.

Scope
Sleep Center of Nevada and future acquisitions
Materiality
high
high

Nasdaq listing and equity requirement compliance

Failure to maintain compliance could impair stock liquidity and capital raising ability.

Scope
Public market access
Materiality
high
high

Regulatory and fee-splitting risk

Managed medical arrangements must comply with state corporate practice and fee-splitting laws.

Scope
Center operations and physician arrangements
Materiality
high
medium

Reimbursement and payer policy risk

Coverage decisions and reimbursement rates affect the economics of sleep testing and treatment.

Scope
Diagnostics and treatment services
Materiality
medium
Revenue recognition under ASC 606
Affects quarterly revenue mix and comparability
Contract liabilities
Can shift revenue between periods
Capitalized software development
Affects operating expense timing and asset balances
Acquisition and intangible asset accounting
Could materially affect balance sheet and earnings
Going-concern and equity deficit disclosures
Important for solvency and valuation analysis

VIVOS INC

RDGL · Surgical & Medical Instruments & Apparatus

Seres Therapeutics, Inc.

MCRB · Pharmaceutical Preparations

VIEMED HEALTHCARE, INC.

VMD · Services-Misc Health & Allied Services, NEC

AVANOS MEDICAL, INC.

AVNS · Orthopedic, Prosthetic & Surgical Appliances & Supplies

LivaNova PLC

LIVN · Electromedical & Electrotherapeutic Apparatus

Inspire Medical Systems, Inc.

INSP · Surgical & Medical Instruments & Apparatus

: 29/04/2026